Litigation Details for CG3 Media, LLC v. Belleau Technologies, LLC (S.D.N.Y. 2021)
✉ Email this page to a colleague
CG3 Media, LLC v. Belleau Technologies, LLC (S.D.N.Y. 2021)
Docket | ⤷ Try a Trial | Date Filed | 2021-05-21 |
Court | District Court, S.D. New York | Date Terminated | 2023-03-09 |
Cause | 28:2201dj Declaratory Judgment | Assigned To | Mary Kay Vyskocil |
Jury Demand | Both | Referred To | |
Patents | 6,011,049 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in CG3 Media, LLC v. Belleau Technologies, LLC
Details for CG3 Media, LLC v. Belleau Technologies, LLC (S.D.N.Y. 2021)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2021-08-03 | 11 | Answer to Counterclaim | 04607-MKV Document 11 Filed 08/03/21 Page 6 of 11 49. With respect to paragraph 49 of the… the Patent-in-Suit. 69. Counter-Defendants state that the claims of the ‘646 Patent are invalid…The asserted claims of the Patent-in-Suit are limited by the text of the Patent-in- Suit, its prosecution…Denied. THE PATENT-IN-SUIT 28. With respect to paragraph… PRE-SUIT NOTICE OF THE ‘646 PATENT 48. Counter-Defendants admit that | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |